Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=23	shorter survival	N=8	longer survival	N=15
AGE	Spearman correlation test	N=1650	older	N=442	younger	N=1208
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=48	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=127	higher stage	N=31	lower stage	N=96
PATHOLOGY N STAGE	Spearman correlation test	N=53	higher stage	N=43	lower stage	N=10
PATHOLOGY M STAGE	Kruskal-Wallis test	N=2236	 	 	 	 
GENDER	Wilcoxon test	N=5	male	N=5	female	N=0
HISTOLOGICAL TYPE	Kruskal-Wallis test	N=6817	 	 	 	 
RADIATIONS RADIATION REGIMENINDICATION	Wilcoxon test	N=1408	yes	N=1408	no	N=0
NUMBER OF LYMPH NODES	Spearman correlation test	N=38	higher number.of.lymph.nodes	N=30	lower number.of.lymph.nodes	N=8
RACE	Kruskal-Wallis test	N=5797	 	 	 	 
ETHNICITY	Wilcoxon test	N=0	 	 	 	 
